Laurion Capital Management »

C4 Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.4M 535k 8.17
2023-06-30 $72k 26k 2.75
2021-12-31 $19M 581k 32.20
2021-09-30 $30M 663k 44.68
2021-06-30 $31M 815k 37.84
2021-03-31 $9.9M 268k 36.99
2020-12-31 $3.6M 110k 33.13

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics